Aggregated News From Investment Management Regulators

Publication of financial reports: Federal Office of Justice imposes disciplinary fine against Elanix Biotechnologies AG

Report/Flag

Please complete the required fields.



On 13 March 2020, the Federal Office of Justice (Bundesamt für JustizBfJ) imposed a disciplinary fine amounting to 2,500 euros against Elanix Biotechnologies AG.

The disciplinary fine order related to a breach of section 325 of the German Commercial Code (HandelsgesetzbuchHGB) by Elanix Biotechnologies AG. Elanix Biotechnologies AG had failed to submit its accounting documents for the financial year 2018 for the purpose of disclosure to the operator of the German Federal Gazette (Bundesanzeiger) in electronic form within the prescribed period. The legal basis for the sanction is section 335 of the HGB.

The company can lodge a complaint against the disciplinary fine order.

Regulator Information

Recent Articles

Retail investors have grown in number, are younger and increasingly use neo-brokers since the Covid crisis

After an initial analysis of the behaviour of retail investors on the stock market conducted in April 2020 during the first lockdown, the Autorité des Marchés Financiers has confirmed the renewed in

The AMF announces two appointments to the Regulatory Policy and International Affairs Directorate (DRAI)

Kheira Benhami has been appointed Chief Economist and Director of the Analysis, Financial Stability and Risks Division at the DRAI as of 2 November, while Ianja Ramananarivo was appointed Head of th

Aclassbank / Bellerophon Group Ltd

Attention! The FMA warns investors against concluding transactions with: Aclassbank / Bellerophon Group Ltd with its registered address apparently in Mauritius and St. Vincent and Grenadines Web: www.aclassbank.com E-Mail:...

Get the latest from Regulatory.News in your inbox!

×